Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine after out-of-hospital cardiac arrest
ISRCTN69111582Phase 2Recruiting
- Sponsor
- Medical University of Vienna
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cardiac arrest (SCA) comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: Neurologic injury. Started Oct 2026; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on ISRCTN69111582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN69111582.